| 
Results for dpp4. Search took 0.17 seconds.
Novartis Diabetes Drug Eucreas, EU-Approved
in Daily Diabetic, on February 25, 2008
The Novartis diabetes pill Eucreas has been approved by The European Union for type 2 diabetes . Eucreas is a combination of Galvus (a DPP-4 inhibitor) and metformin (a popular diabetes drug which decreases the production of sugar by the liver and increases insulin sensitivity).
Galvus is ...
Takeda Filed for US Approval of Diabetes Drug Alogliptin
in Daily Diabetic, on January 4, 2008
The Japanese pharmaceutical company - Takeda - announced that it is seeking U.S. approval of its diabetes Drug Alogliptin (SYR-322) .
Alogliptin is a diabetes drug that Takeda hopes to replace Actos (Pioglitazone HCl) - another Takeda diabetes drug.
[Alogliptin, or SYR-322, is in ...
DPP-4 Inhibitor JANUVIA® Approved In EU for Type 2 Diabetes
in Daily Diabetic, on March 27, 2007
For starters let me pick on the most common type of diabetes: type 2 diabetes -where either the body does not produce enough insulin or the body's cells are resistant to insulin - both cases leading to high blood sugar .
However, this shouldn't cause us to panic, because th...